Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy. (March 2019) - Cabioglu, N.; Onder, S.; Oner, G.; Karatay, H.; Özkurt, E.; CanTrablus, D.; Tukenmez, M.; Muslumanoglu, M.; Saip, P.; Yavuz, E.; ,